What is the best approach to the teenage patient presenting with nonclassical Congenital adrenal hyperplasia: should we always treat with glucocorticoids?

Authors

  • Deborah Matthews,

    1. Department of Paediatric Endocrinology, c/o Old Children's Out Patients, Royal Victoria Infirmary, Newcastle-upon-Tyne
    Search for more papers by this author
  • Tim Cheetham

    Corresponding author
    1. Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK
    • Department of Paediatric Endocrinology, c/o Old Children's Out Patients, Royal Victoria Infirmary, Newcastle-upon-Tyne
    Search for more papers by this author

Correspondence: Tim Cheetham, Department of Paediatric Endocrinology, c/o Old Children's Out Patients, Royal Victoria Infirmary, Newcastle-upon-Tyne, NE1 4LP, UK. Tel.: (0044)1912829562; Email: tim.cheetham@nuth.nhs.uk

Summary

Patients with Congenital adrenal hyperplasia due to partial deficiency in the enzyme 21-hydroxlyase can present in childhood or adolescence with signs of adrenal androgen excess. Strategies to reduce the impact of androgen excess in females include cosmetic measures as well as antiandrogens and agents such as the combined oral contraceptive pill. Glucocorticoid may not be appropriate straightaway but can be introduced if other measures are ineffective or when pregnancy is planned.

Ancillary